SBC (SBC Medical Group Holdings) Debt-to-EBITDA : 0.44 (As of Dec. 2024)

View and export this data going back to 2024. Start your Free Trial

What is SBC Medical Group Holdings Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

SBC Medical Group Holdings's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was $4.5 Mil. SBC Medical Group Holdings's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was $7.8 Mil. SBC Medical Group Holdings's annualized EBITDA for the quarter that ended in Dec. 2024 was $28.0 Mil. SBC Medical Group Holdings's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2024 was 0.44.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for SBC Medical Group Holdings's Debt-to-EBITDA or its related term are showing as below:

SBC' s Debt-to-EBITDA Range Over the Past 10 Years
Min: 0.16 Med: 0.27 Max: 0.54
Current: 0.26

During the past 3 years, the highest Debt-to-EBITDA Ratio of SBC Medical Group Holdings was 0.54. The lowest was 0.16. And the median was 0.27.

SBC's Debt-to-EBITDA is ranked better than
84.88% of 820 companies
in the Business Services industry
Industry Median: 1.7 vs SBC: 0.26

SBC Medical Group Holdings Debt-to-EBITDA Historical Data

The historical data trend for SBC Medical Group Holdings's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SBC Medical Group Holdings Debt-to-EBITDA Chart

SBC Medical Group Holdings Annual Data

Trend

Dec22

Dec23

Dec24

Debt-to-EBITDA

0.54

0.27

0.16

SBC Medical Group Holdings Quarterly Data
	Dec22	Sep23	Dec23	Jun24	Sep24	Dec24
Debt-to-EBITDA	Get a 7-Day Free Trial			-	0.22	0.27	0.54	0.44

Competitive Comparison of SBC Medical Group Holdings's Debt-to-EBITDA

For the Consulting Services subindustry, SBC Medical Group Holdings's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

SBC Medical Group Holdings's Debt-to-EBITDA Distribution in the Business Services Industry

For the Business Services industry and Industrials sector, SBC Medical Group Holdings's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where SBC Medical Group Holdings's Debt-to-EBITDA falls into.

Save Embed

;

Save Embed

;

SBC Medical Group Holdings Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

SBC Medical Group Holdings's Debt-to-EBITDA for the fiscal year that ended in Dec. 2024 is calculated as

Debt-to-EBITDA	=	Total Debt			/	EBITDA
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	EBITDA
	=	(4.465	+	7.75)	/	77.283
	=	0.16

SBC Medical Group Holdings's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2024 is calculated as

Debt-to-EBITDA	=	Total Debt			/	EBITDA
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	EBITDA
	=	(4.465	+	7.75)	/	28.012
	=	0.44

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Dec. 2024) EBITDA data.

SBC Medical Group Holdings (NAS:SBC) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.

Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

SBC Medical Group Holdings Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of SBC Medical Group Holdings's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

SBC Medical Group Holdings Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Industrials » Business Services » SBC Medical Group Holdings Inc (NAS:SBC) » Definitions » Debt-to-EBITDA

Comparable Companies

Traded in Other Exchanges

N/A

Address

200 Spectrum Center Drive, Suite 300, Irvine, CA, USA, 163-1303

Website

https://www.sbc-med.com

SBC Medical Group Holdings Inc is a management company that provides management services to cosmetic treatment centers mainly in Japan. It is focused on providing comprehensive management services to franchisee clinics, including but not limited to advertising and marketing needs across various platforms (such as social media networks), staff management (such as recruitment and training), booking reservations for franchisee clinic customers, assistance with franchisee employee housing rentals and facility rentals, construction and design of franchisee clinics, medical equipment and medical consumables procurement (resale). Company provide management services to a total of One hundred fifty eight franchisee treatment centers under the brand name Shonan Beauty Clinic located in Japan.